The purpose of this study is to evaluate safety and effectiveness of AcrySof® IQ ReSTOR® +3.0
D Multifocal Toric IOL Models SND1T3, SND1T4, SND1T5, and SND1T6 when implanted to replace
the natural lens in Japanese cataract patients.
Device: AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01323777
Ages eligible for Study
20 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Sign informed consent;
Diagnosed with bilateral cataracts;
Planned cataract removal by phacoemulsification;
Potential postoperative visual acuity of 0.6 decimal or better in both eyes;
Preoperative astigmatism ≥ 0.75 diopter;
Clear intraocular media other than cataract in study eyes;
Calculated lens power and astigmatism within the available range;
Pupil size greater than or equal to 6 mm after dilation;
Able to undergo second eye surgery within 30 days of the first eye surgery;
Other protocol-defined inclusion criteria may apply.
Irregular corneal aberration as demonstrated by corneal topography;
Any inflammation or edema (swelling) of the cornea;
Diagnosed degenerative visual disorders predicted to cause future acuity losses to a level worse than 0.6 decimal;
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.